Prelude Therapeutics Competitors and Similar CompaniesClear all
Prelude Therapeutics's competitors and similar companies include Mercia Pharma, Ayala Pharmaceuticals, Cytovac and CiMaas.
 Prelude Therapeutics Prelude Therapeutics is a biotechnology company that discovers and develops medicines targeting chromatin function to treat cancer and rare diseases. |  Mercia Pharma Mercia Pharma is a biotech company that develops disease-specific immunotherapeutic products. |  Ayala Pharmaceuticals Ayala Pharmaceuticals is a clinical-stage biopharmaceutical company developing medicines for cancers that are genetically defined. |  Cytovac Cytovac is a clinical-stage biopharmaceutical company dedicated to the discovery and development of immunotherapies with a primary focus on orphan diseases. | ||
Founding Date | Founding Date 2016 | Founding Date N/A | Founding Date 2017 | Founding Date 2008 | Founding Date 2015 |
Type | Type Private | Type Private | Type Public | Type Private | Type Private |
Tags | |||||
Locations | Locations Wilmington, US HQ Canton, US | Locations HQ | Locations Wilmington, US HQ Rehovot, IL Wilmington, US | Locations Hørsholm, DK HQ | Locations Maastricht, NL HQ Maastricht, NL |
Employees | Employees 1372% decrease | Employees 6 | Employees 29 | Employees 713% decrease | Employees 350% increase |
Funding | |||||
Total funding raised | Total funding raised $ 122m | Total funding raised N/A | Total funding raised $ 47m | Total funding raised N/A | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Mercia Pharma
HQ
Employees
6
Mercia Pharma is a biotech company that develops disease-specific immunotherapeutic products.
View companyAyala Pharmaceuticals
HQ
Wilmington, US
Employees
29
Ayala Pharmaceuticals is a clinical-stage biopharmaceutical company developing medicines for cancers that are genetically defined.
View companyCytovac
HQ
Hørsholm, DK
Employees
7↓ 13% decrease
Cytovac is a clinical-stage biopharmaceutical company dedicated to the discovery and development of immunotherapies with a primary focus on orphan diseases.
View company
CiMaas
HQ
Maastricht, NL
Employees
3↑ 50% increase
CiMaas is a company that develops immunotherapy for cancer by engaging the immune system.
View company